Podcast
MSL Talk: Tom Caravela, Chris Castin
Over-Negotiation-How to Botch a Job Offer
Summary
In this episode, Tom Caravela warns job seekers about over negotiation and making unnecessary mistakes in the offer process. Tom debunks common myths and provides essential strategies for Medical Science Liaisons (MSLs) when considering job offers. He stresses the importance of understanding "best and final" offers, knowing one's value, and evaluating compensation ranges. Tom highlights the role of attitude and professionalism in negotiations, warning against aggressive tactics. He also emphasizes the importance of selecting the right mentors and asking essential questions during discussions. The episode concludes with key takeaways on balancing negotiation tactics with long-term career goals and making a positive impression.
Key Points
- Over-negotiating a job offer can lead to losing the opportunity, even if the initial offer was highly favorable.
- It's essential to know your current compensation details and understand the company's salary range to avoid unrealistic expectations during negotiations.
- Approaching negotiations with gratitude and a positive attitude is crucial, as it sets the tone for your future relationship with the employer and can prevent offers from being rescinded.
Job Offer Negotiation, Medical Science Liaison Tips, MSL Career Strategies, Understanding Compensation Ranges, Professionalism in Negotiations, Selecting the Right Mentors, Avoiding Aggressive Tactics, Long-term Career Goals, Positive Impression in Interv
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Chris Castin
Podcast
MSL Talk: Tom Caravela, Kunal Ramani
Do What Other Don't-Opportunity in a Saturated Market
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary